This statistic shows the compound annual growth rates of selected pharmaceutical major therapeutic classes in 2014-2018, based on spending. In that period, spending on autoimmune agents increased with a compound annual growth rate of 15.4 percent. For pain drugs, an increase of 0.9 percent annually was reported for the same period.
Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Pharmaceutical industry - sales growth by therapeutic classes
- Sales growth of pharmaceutical therapeutic areas
- Sales of the top pharmaceutical therapeutic areas
- U.S. costs saved through generics by therapy 2004-2013
- Pharmaceutical industry: EU trade partners in import 2010-2018
- Total per-study costs by clinical trial phase and therapeutic area
- Global pharmaceutical pipeline by therapy area 2013-2017
- Global pharmaceutical product launches by therapy area 2004-2013
- U.S. pharmaceutical industry spending on research and development 1990-2018
- Increase in research collaborations between 2005 and 2014 U.S. by type
- Availability of new medicines in selected countries 2013
- Pharmacy market sales' parallel import share - European countries 2017
- Share value of the generic pharmaceuticals market in Czechia 2001-2016
- Share value of the generic pharmaceuticals market in Slovakia 2000-2017
- Most commonly used prescription drugs Australia 2018
- Sales value of agents acting on the musculo-skeletal system in Spain 2004-2017
- United Kingdom (UK): pharmaceutical products export value to Poland 2012-2018
- Top cholesterol drugs in the U.S. by revenue 2011-2012
- Value of hypnotics and sedatives pharmaceutical sales in Spain 2004-2017
- Italy: pharmaceuticals products retail sales 2017-2019
Further related statistics
IQVIA. (January 31, 2019). Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* [Graph]. In Statista. Retrieved December 10, 2019, from https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. "Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*." Chart. January 31, 2019. Statista. Accessed December 10, 2019. https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. (2019). Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*. Statista. Statista Inc.. Accessed: December 10, 2019. https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. "Global Spending Growth in Selected Pharmaceutical Major Therapeutic Classes between 2014 and 2018*." Statista, Statista Inc., 31 Jan 2019, https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA, Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* Statista, https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/ (last visited December 10, 2019)